ХРАНЕНИЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ И ДРУГИХ ТОВАРОВ, РЕАЛИЗУЕМЫХ В АПТЕЧНЫХ ОРГАНИЗАЦИЯХ РЕСПУБЛИКИ ТАДЖИКИСТАН: АКТУАЛЬНОСТЬ, ПРОБЛЕМА, ПУТИ РЕШЕНИЯ

Abstract

Relevance: Since gaining state independence, state reforms have been actively continuing in the Republic of Tajikistan, including the field of drug development, the study of problems related to the storage of pharmaceutical assortment products and the formation of requirements for the organization of appropriate storage conditions for drugs is a relevant and timely step towards the development of rules of national pharmaceutical practice and standardization of the drug development field in the region. Objective: Study of the existing state of the pharmaceutical assortment products storage organization, including problems that may affect the proper placement of pharmaceutical assortment products at the places of main storage, and development of proposals for the formation of the storage order from the standpoint of minimizing potential risks of quality loss of products at the stage of their placement and storage in pharmacy organizations. Materials and methods: Through content analysis, the content of regulatory legal documents regulating the drug development field and other products sold in pharmacy organizations of the Republic of Tajikistan has been studied in order to establish legal gaps in the problem under study. With the use of structural and logical analyses, the potential risks of organizing pharmaceutical activities that have an impact on the quality of products during their storage are determined. By means of structural analysis, the climatic storage conditions of pharmaceutical assortment products are systematized. The developed structure is the basis for further grouping of products to determine their storage locations in pharmacy organizations. Results: Compliance with the necessary storage conditions established by the manufacturer of products is a key aspect of ensuring the quality of products and requires the development and establishment of the procedure for organizing and observing the storage of medicines and other pharmaceutical products at the legislative level, however, in the Republic of Tajikistan there are no approved norms, rules and standards for organizing the storage of pharmaceutical assortment products. The study and optimization of storage sites was carried out by grouping the products according to the following criteria: type of group of drugs, medical devices (MI), biologically active food supplements (BAFS), etc.), requirements for climatic storage conditions and the need for protection from exposure to light. During the study, 25 options of the storage regime of drugs, 16 storage options for MI and BAFS were identified, representing various combinations of the established storage conditions. It was found that some drugs and MI (more than 40) with the same trade names, but different manufacturers, may require different temperature storage conditions and may lead to errors when placing medicines data in their main storage locations. Drugs, the storage modes of which have an insignificant temperature range of storage, have been identified. The presence of such drugs in the assortment of pharmacy organizations requires additional professional vigilance from pharmaceutical workers at the stage of acceptance and placement of products. Conclusion: The article presents the results of studying the storage conditions of pharmaceutical products sold in the Republic of Tajikistan. The expediency of determining storage locations for various groups of products and individual items depending on their storage conditions is actualized and the need to improve the organization of storage by developing requirements for the organization of storage locations in the subjects of drug development is justified.